93450-5

LOINC 2.82

Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method

Fact VIII Inhib PPP Chro-aCnc

Definition

  • This term is created for but not restricted in use to a Nijmegen modification of the classic Bethesda inhibitor titration assay using a chromogenic method. The use of a chromogenic method allows factor VIII inhibitor to be detected in patients receiving emicizumab / Hemlibra®, a therapeutic that interferes with standard clot-based methods [PMID:29446525].

Component

  • Coagulation factor VIII Inhibitor

Specimen / system

  • PPP

Class

  • COAG

Property

  • ACnc

Scale

  • Qn

Method

  • Chromo

Related names

  • AHF; AHG; Antihemophilic factor; Antihemophilic globulin; Arbitrary concentration; Chromogenic assay; Circulating anticoagulant; Coag; ENZY; Enzymatic assay; F8; Fac; Fact; Fact VIII; Fact VIII Inhib; Factor 8; Factor VIII clotting activity; FVIII; Inhib; Inhibit; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte cofactor A; VIII:C

Index terms

  • AHF
  • AHG
  • Antihemophilic factor
  • Antihemophilic globulin
  • Arbitrary concentration
  • Chromogenic assay
  • Circulating anticoagulant
  • Coag
  • ENZY
  • Enzymatic assay
  • F8
  • Fac
  • Fact
  • Fact VIII
  • Fact VIII Inhib
  • Factor 8
  • Factor VIII clotting activity
  • FVIII
  • Inhib
  • Inhibit
  • Plas
  • Platelet poor plasma
  • Point in time
  • QNT
  • Quan
  • Quant
  • Quantitative
  • Random
  • Thrombocyte cofactor A
  • VIII:C